Chondrosarcoma

What chondrosarcoma is — in plain words

Cartilage is the smooth, slightly rubbery tissue that lines our joints and forms part of our skeleton — particularly during growth. Chondrosarcoma is a cancer in which cartilage-producing cells start dividing in a disordered way and form a tumour, usually inside or on the surface of a bone.

The most important thing to understand about chondrosarcoma is that it is not one disease. It is a spectrum. At one end, low-grade chondrosarcoma is so indolent that it can sit quietly for years. At the other end, high-grade and dedifferentiated chondrosarcomas behave aggressively and need a much more involved plan. Your treatment will be tailored to where on that spectrum your tumour sits.

Who tends to get it

• Mostly adults, typically aged 40 to 70. Unlike osteosarcoma and Ewing sarcoma, chondrosarcoma is uncommon in children and teenagers.
• Slightly more common in men than in women.
• Sometimes arises in a pre-existing benign cartilage growth — for example, an enchondroma or a hereditary multiple exostoses lesion. Most chondrosarcomas, however, arise without any known precursor.

Where it usually shows up

The signs that should not be ignored

Chondrosarcoma is one of those cancers where, in hindsight, the symptoms had been there for a long time. Because the pain is dull and the lump is painless, people sometimes wait for many months. If something is steadily getting worse over weeks rather than improving, please come in.

"Chondrosarcoma is the cancer that rewards a careful surgeon more than almost any other. The first operation is by far the most important — get the margins right and we have done most of the work; get them wrong and the rest of the journey becomes much harder."

How chondrosarcoma is diagnosed

• Plain X-ray. Often the first clue — a mass inside or on the surface of a bone, typically containing patchy or ring-like calcifications. The pattern can be characteristic, but it can also overlap with benign cartilage lesions.
• MRI. The single most important imaging test for chondrosarcoma. It shows the exact size, the soft-tissue extent, and (very importantly) features that suggest whether a lesion is benign, low-grade or high-grade.
• CT scan. Useful for showing the bony detail and the calcifications inside the tumour, and essential for chest-wall, spinal and pelvic tumours.
• CT scan of the chest. To check for lung metastases at diagnosis.
• Biopsy — important, but tricky. Cartilage tumours are notoriously difficult to grade on a small biopsy sample. The tumour is often a mixture of low-grade and higher-grade areas, and a needle can miss the worst part. The biopsy must be planned by the surgeon who will eventually operate, and should be interpreted by a specialist sarcoma pathologist who looks at the imaging alongside the slides.

Grades — the single most important number

The grade is the strongest single predictor of how a chondrosarcoma will behave. Two patients with the same-sized tumour can have completely different journeys depending on whether it is grade 1 or grade 3.

How chondrosarcoma is treated

Surgery — the main treatment

For the great majority of chondrosarcomas, surgery is the main and often the only treatment. The goal is wide local excision: the entire tumour removed with a healthy margin of normal tissue around it. There are good reasons for this surgical focus:

• Chondrosarcoma is famously resistant to chemotherapy for the common (conventional) subtypes. The drugs that work so well in osteosarcoma and Ewing sarcoma do very little here.
• It is also relatively resistant to standard radiation therapy. Specialised forms of radiation (proton beam or carbon-ion therapy) have a role for tumours where surgery cannot completely remove the disease — particularly skull base and spinal chondrosarcomas — but they are not widely available.

This is why the first operation matters more in chondrosarcoma than in almost any other sarcoma. A well-planned, complete resection gives the best chance of cure. An incomplete resection that leaves microscopic disease behind cannot be reliably rescued by chemotherapy or radiation afterwards.

For limb chondrosarcomas, limb-sparing surgery is almost always possible. For pelvic, spinal and skull base tumours, surgery is more complex and may need a joint team of orthopaedic, plastic and reconstructive surgeons.

Chemotherapy — a limited role for most subtypes

For conventional grade 1, 2 and 3 chondrosarcomas, chemotherapy has not been shown to improve outcomes and is generally not used. This is one of the few cancers where we actively spare patients chemotherapy because it does not help. Read more about chemotherapy →

Radiation therapy — selected situations

Radiation is considered when surgery cannot achieve a complete clearance — for example, for tumours of the skull base, spine or pelvis where vital structures limit how much can be removed. Where available, advanced techniques (proton or carbon-ion therapy) are particularly useful for these difficult locations.

The aggressive subtypes — where chemotherapy does come in

Two specific subtypes of chondrosarcoma break the usual rules and behave more like other bone sarcomas:

If your pathology report mentions either of these subtypes, the treatment plan looks different from conventional chondrosarcoma. We will explain exactly why and what it means for you.

What the outlook honestly looks like

Survival in chondrosarcoma depends very heavily on two things: the grade of the tumour, and whether the surgery achieved a complete (clean-margin) resection.

Local recurrence — the cancer coming back at the original site — is the main concern, particularly when the surgical margin was close. This is why follow-up imaging continues for many years after the operation.

Life during and after treatment

For most patients with conventional chondrosarcoma, treatment is concentrated around the operation itself rather than spread over many months. The hardest period is usually the surgery and the rehabilitation that follows.

• Recovery from limb surgery takes weeks to months, with structured physiotherapy. Most patients regain a very good level of function.
• Recovery from pelvic or chest-wall surgery takes longer and may involve a longer hospital stay, careful pain management and a more extended rehabilitation plan.
• Returning to work and normal life is realistic for the great majority of patients. Many continue all of their normal activities.
• Mental health matters even when treatment is "just" surgery. Adjusting to a cancer diagnosis, to scars, to changes in how a limb feels, and to a long period of follow-up is real work. Please raise it with us.

Follow-up — long and important

Because chondrosarcoma can recur locally even years after surgery, follow-up continues for a long time. A typical schedule includes clinic visits and imaging (MRI of the operated site and CT chest) every few months for the first two to three years, then less frequently for at least ten years in total. We tailor the schedule to the grade of the original tumour.

Related services

• Overview of sarcomas
• Osteosarcoma
• Ewing sarcoma
• Multidisciplinary care
• Radiation therapy
• Second opinion
• Survivorship care